UPDATE ON DIAGNOSIS AND MANAGEMENT OF FETAL … · PROBLEM: MANAGEMENT PROBLEM: DIAGNOSIS Placental...

Preview:

Citation preview

www.fetalmedicinebarcelona.org/

UPDATE ON DIAGNOSIS AND MANAGEMENT OF

FETAL GROWTH RESTRICTIONEduard Gratacos

Servicio de Medicina MaternofetalHospital Clinic y Hospital Sant Joan de Deu - Universidad de Barcelona

www.fetalmedicinebarcelona.org

www.medicinafetalbarcelona.org/

1. Identify small fetus

2. FGR vs. SGA

3. Early vs. Late

4. Stage-based management protocol

www.medicinafetalbarcelona.org/

1. Identify small fetus

2. FGR vs. SGA

3. Early vs. Late

4. Stage-based management protocol

www.medicinafetalbarcelona.org/

Neonatal and Fetal GA-adjusted “normal” weight in the same population

www.medicinafetalbarcelona.org/

Neonatal and Fetal GA-adjusted “normal” weight in the same population

www.medicinafetalbarcelona.org/

1. Identify small fetus

2. FGR vs. SGA

3. Early vs. Late

4. Stage-based management protocol

www.medicinafetalbarcelona.org/

ISOLATED FETAL SMALLNESS = POORER PROGNOSISPerinatal and Long-term Outcomes

Exclude extrinsic cause

Exclude primary fetal defect

www.medicinafetalbarcelona.org/

ISOLATED FETAL SMALLNESS = POORER PROGNOSISPerinatal and Long-term Outcomes

Exclude extrinsic cause

Exclude primary fetal defect

Poor perinatal outcome + IUFD(Doppler) Signs of adaptation

www.medicinafetalbarcelona.org/

ISOLATED FETAL SMALLNESS = POORER PROGNOSISPerinatal and Long-term Outcomes

Exclude extrinsic cause

Exclude primary fetal defect

Poor perinatal outcome + IUFD(Doppler) Signs of adaptation

Perinatal outcome normal - No IUFDNO signs of adaptation

www.medicinafetalbarcelona.org/

SGA Unknown (constitutional + others)

IUGRPlacental insufficiency

ISOLATED FETAL SMALLNESS = POORER PROGNOSISPerinatal and Long-term Outcomes

Exclude extrinsic cause

Exclude primary fetal defect

Poor perinatal outcome + IUFD(Doppler) Signs of adaptation

Perinatal outcome normal - No IUFDNO signs of adaptation

www.medicinafetalbarcelona.org/

SGA Unknown (constitutional + others)

IUGRPlacental insufficiency

ISOLATED FETAL SMALLNESS = POORER PROGNOSISPerinatal and Long-term Outcomes

Exclude extrinsic cause

Exclude primary fetal defect

Poor perinatal outcome + IUFD(Doppler) Signs of adaptation

Perinatal outcome normal - No IUFDNO signs of adaptation

www.medicinafetalbarcelona.org/

SGA Unknown (constitutional + others)

IUGRPlacental insufficiency

ISOLATED FETAL SMALLNESS = POORER PROGNOSISPerinatal and Long-term Outcomes

Exclude extrinsic cause

Exclude primary fetal defect

Poor perinatal outcome + IUFD(Doppler) Signs of adaptation

Perinatal outcome normal - No IUFDNO signs of adaptation

FGR vs. SGA: DIFFERENT MANAGEMENT

www.medicinafetalbarcelona.org/

Constitutionally small Placental insufficiency Extrinsic cause

Primary fetal defect

SGA FGR

The discovery of UA and hemodynamics of IUGR

www.medicinafetalbarcelona.org/

Constitutionally small Placental insufficiency Extrinsic cause

Primary fetal defect

SGA FGR

The discovery of UA and hemodynamics of IUGR

20 30 4025 35

0

N  cases

N  cases

www.medicinafetalbarcelona.org/

Constitutionally small Placental insufficiency Extrinsic cause

Primary fetal defect

SGA FGR

The discovery of UA and hemodynamics of IUGR

20 30 4025 35

0

N  cases

N  cases

UA Doppler +(EARLY-ONSET)

www.medicinafetalbarcelona.org/

Constitutionally small Placental insufficiency Extrinsic cause

Primary fetal defect

SGA FGR

The discovery of UA and hemodynamics of IUGR

20 30 4025 35

0

N  cases

N  cases

UA Doppler +(EARLY-ONSET)

UA Doppler N(LATE-ONSET)

Savchev  2013

www.medicinafetalbarcelona.org/

Constitutionally small Placental insufficiency Extrinsic cause

Primary fetal defect

SGA FGR

The discovery of UA and hemodynamics of IUGR

FGR = abnormal UA Doppler

20 30 4025 35

0

N  cases

N  cases

UA Doppler +(EARLY-ONSET)

UA Doppler N(LATE-ONSET)

Savchev  2013

www.medicinafetalbarcelona.org/

0

10

20

30

40

Neonatal acidosis CS for distress Abnormal NBAS Any

%

Figueras 2011

SGA: proportion of perinatal adverse outcomes in 376 consecutive cases

www.medicinafetalbarcelona.org/

IMPACT OF NON-DETECTED IUGR ON LATE FETAL MORTALITYHospital Clínic Barcelona2005-2010

0%

10%

20%

30%

40%

50%

FGR Unknown Others

25%30%

45%

Relevant Condition ReCoDe

www.medicinafetalbarcelona.org/

IMPACT OF NON-DETECTED IUGR ON LATE FETAL MORTALITYHospital Clínic Barcelona2005-2010

0%

10%

20%

30%

40%

50%

FGR Unknown Others

25%30%

45%

Relevant Condition ReCoDe

Impact of growth restriction in late pregnancy stillbirthGardosi et al. BMJ 2005, 2013

N=2625 stillbirths

FGR as relevant condition identified in 43-60%

UtA >p95

CPR <p5 EFW CENTILE <3

Prognostic criteria of “poor outcome”-SGACS for distress and/or neonatal acidosis

N=447 SGA + 447 controls

Figueras 2012

UtA >p95

CPR <p5 EFW CENTILE <3

Prognostic criteria of “poor outcome”-SGACS for distress and/or neonatal acidosis

N=447 SGA + 447 controls

Figueras 2012

UtA >p95

CPR <p5 EFW CENTILE <3

0%

10%

20%

30%

40%

50%

Controls All normal Any abnormal

Prognostic criteria of “poor outcome”-SGACS for distress and/or neonatal acidosis

N=447 SGA + 447 controls

Figueras 2012

UtA >p95

CPR <p5 EFW CENTILE <3

0%

10%

20%

30%

40%

50%

8%

Controls All normal Any abnormal

Prognostic criteria of “poor outcome”-SGACS for distress and/or neonatal acidosis

N=447 SGA + 447 controls

Figueras 2012

UtA >p95

CPR <p5 EFW CENTILE <3

0%

10%

20%

30%

40%

50%

8%11%

Controls All normal Any abnormal

Prognostic criteria of “poor outcome”-SGACS for distress and/or neonatal acidosis

N=447 SGA + 447 controls

Figueras 2012

UtA >p95

CPR <p5 EFW CENTILE <3

0%

10%

20%

30%

40%

50%

8%11%

40%

Controls All normal Any abnormal

%

Prognostic criteria of “poor outcome”-SGACS for distress and/or neonatal acidosis

N=447 SGA + 447 controls

Figueras 2012

www.medicinafetalbarcelona.org/

Distribution of cases when IUGR = abnormal UA Doppler

Savchev 2013

www.medicinafetalbarcelona.org/

Distribution of cases when IUGR = abnormal CPR or UtA or EFW<p3

Savchev 2013

www.medicinafetalbarcelona.org/

1. Identify small fetus

2. FGR vs. SGA

3. Early vs. Late

4. Stage-based management protocol

www.fetalmedicinebarcelona.org/

IUGR

SGA?

20 30 4025 35

0

3

6 %

IUGR= low CPR or high UtA or EFW<p3 or low PlGF

www.fetalmedicinebarcelona.org/

IUGR

SGA?

20 30 4025 35

0

3

6 %

IUGR= low CPR or high UtA or EFW<p3 or low PlGF

32w @diagnosis

www.fetalmedicinebarcelona.org/

IUGR

SGA?

20 30 4025 35

0

3

6 %

IUGR= low CPR or high UtA or EFW<p3 or low PlGF

EARLY IUGR (1%) LATE IUGR (5-7%)

32w @diagnosis

www.fetalmedicinebarcelona.org/

IUGR

SGA?

20 30 4025 35

0

3

6 %

IUGR= low CPR or high UtA or EFW<p3 or low PlGF

EARLY IUGR (1%) LATE IUGR (5-7%)

PROBLEM: MANAGEMENT PROBLEM: DIAGNOSIS

32w @diagnosis

www.fetalmedicinebarcelona.org/

IUGR

SGA?

20 30 4025 35

0

3

6 %

IUGR= low CPR or high UtA or EFW<p3 or low PlGF

EARLY IUGR (1%) LATE IUGR (5-7%)

PROBLEM: MANAGEMENT PROBLEM: DIAGNOSIS

Placental disease: high (UA+, PE high) Placental disease: low (UA-, PE low)

32w @diagnosis

www.fetalmedicinebarcelona.org/

IUGR

SGA?

20 30 4025 35

0

3

6 %

IUGR= low CPR or high UtA or EFW<p3 or low PlGF

EARLY IUGR (1%) LATE IUGR (5-7%)

PROBLEM: MANAGEMENT PROBLEM: DIAGNOSIS

Placental disease: high (UA+, PE high) Placental disease: low (UA-, PE low)

Hypoxia ++: systemic CV adaptation Hypoxia +/-: central CV adaptation

32w @diagnosis

www.fetalmedicinebarcelona.org/

IUGR

SGA?

20 30 4025 35

0

3

6 %

IUGR= low CPR or high UtA or EFW<p3 or low PlGF

EARLY IUGR (1%) LATE IUGR (5-7%)

PROBLEM: MANAGEMENT PROBLEM: DIAGNOSIS

Placental disease: high (UA+, PE high) Placental disease: low (UA-, PE low)

Hypoxia ++: systemic CV adaptation Hypoxia +/-: central CV adaptation

Tolerance to hypoxia. Natural history Low tolerance: no natural history

32w @diagnosis

www.fetalmedicinebarcelona.org/

IUGR

SGA?

20 30 4025 35

0

3

6 %

IUGR= low CPR or high UtA or EFW<p3 or low PlGF

EARLY IUGR (1%) LATE IUGR (5-7%)

PROBLEM: MANAGEMENT PROBLEM: DIAGNOSIS

Placental disease: high (UA+, PE high) Placental disease: low (UA-, PE low)

Hypoxia ++: systemic CV adaptation Hypoxia +/-: central CV adaptation

Tolerance to hypoxia. Natural history Low tolerance: no natural history

High mortality and morbidity Low mortality but poor long outcome.

32w @diagnosis

www.fetalmedicinebarcelona.org/

FETAL DETERIORATION IN PLACENTAL INSUFFICIENCY

PLACENTAL DISEASE COMPENSATED HYPOXIA DECOMPENSATED HYPOXIA SERIOUS INJURYDEATH

cardiac ischemiaDiastolic failure

Systolic cardiac failure

Centralization

Increment placental impedance

growth

MIDDLE CEREBRAL A. <p5

CPR <p5

CTG ABNORMAL

UMBILICAL A. >p95

www.fetalmedicinebarcelona.org/

FETAL DETERIORATION IN PLACENTAL INSUFFICIENCY

PLACENTAL DISEASE COMPENSATED HYPOXIA DECOMPENSATED HYPOXIA SERIOUS INJURYDEATH

cardiac ischemiaDiastolic failure

Systolic cardiac failure

Centralization

Increment placental impedance

growth

MIDDLE CEREBRAL A. <p5

CPR <p5

DUCTUS VENOSUS >p95 and a-

CTG ABNORMAL

UMBILICAL A. >p95

www.fetalmedicinebarcelona.org/

FETAL DETERIORATION IN PLACENTAL INSUFFICIENCY

PLACENTAL DISEASE COMPENSATED HYPOXIA DECOMPENSATED HYPOXIA SERIOUS INJURYDEATH

cardiac ischemiaDiastolic failure

Systolic cardiac failure

Centralization

Increment placental impedance

growth

MIDDLE CEREBRAL A. <p5

CPR <p5

DUCTUS VENOSUS >p95 and a-

CTG ABNORMAL

UTERINE A. >p95

UMBILICAL A. >p95

www.fetalmedicinebarcelona.org/

FETAL DETERIORATION IN PLACENTAL INSUFFICIENCY

PLACENTAL DISEASE COMPENSATED HYPOXIA DECOMPENSATED HYPOXIA SERIOUS INJURYDEATH

cardiac ischemiaDiastolic failure

Systolic cardiac failure

Centralization

Increment placental impedance

growth

MIDDLE CEREBRAL A. <p5

CPR <p5

DUCTUS VENOSUS >p95 and a-

CTG ABNORMAL

UTERINE A. >p95

cCTG: reduced short-term variability

UMBILICAL A. >p95

www.fetalmedicinebarcelona.org/

FETAL DETERIORATION IN PLACENTAL INSUFFICIENCY

PLACENTAL DISEASE COMPENSATED HYPOXIA DECOMPENSATED HYPOXIA SERIOUS INJURYDEATH

cardiac ischemiaDiastolic failure

Systolic cardiac failure

Centralization

Increment placental impedance

growth

MIDDLE CEREBRAL A. <p5

CPR <p5

DUCTUS VENOSUS >p95 and a-

CTG ABNORMAL

UTERINE A. >p95

cCTG: reduced short-term variability

Ao ISTHMUS >p95

UMBILICAL A. >p95

www.medicinafetalbarcelona.org/

FETAL DETERIORATION IN PLACENTAL INSUFFICIENCY EARLY VS LATE IUGR (>34s)

PLACENTAL DISEASE COMPENSATED HYPOXIA DECOMPENSATED HYPOXIA SERIOUS INJURYDEATH

cardiac ischemiaDiastolic failure

Systolic cardiac failure

growth

UMBILICAL A. >p95

DUCTUS VENOSUS >p95 and a-

CTG / BPP ABNORMAL

MIDDLE CEREBRAL A. <p5

CPR <p5

Centralization

Increment placental impedance

www.medicinafetalbarcelona.org/

FETAL DETERIORATION IN PLACENTAL INSUFFICIENCY EARLY VS LATE IUGR (>34s)

PLACENTAL DISEASE COMPENSATED HYPOXIA DECOMPENSATED HYPOXIA SERIOUS INJURYDEATH

cardiac ischemiaDiastolic failure

Systolic cardiac failure

growth

UMBILICAL A. >p95

DUCTUS VENOSUS >p95 and a-

CTG / BPP ABNORMAL

Placental injury <30%

MIDDLE CEREBRAL A. <p5

CPR <p5

Centralization

Increment placental impedance

www.medicinafetalbarcelona.org/

FETAL DETERIORATION IN PLACENTAL INSUFFICIENCY EARLY VS LATE IUGR (>34s)

PLACENTAL DISEASE COMPENSATED HYPOXIA DECOMPENSATED HYPOXIA SERIOUS INJURYDEATH

cardiac ischemiaDiastolic failure

Systolic cardiac failure

growth

UMBILICAL A. >p95

DUCTUS VENOSUS >p95 and a-

CTG / BPP ABNORMAL

Placental injury <30%

MIDDLE CEREBRAL A. <p5

CPR <p5

Centralization

Increment placental impedance

www.medicinafetalbarcelona.org/

FETAL DETERIORATION IN PLACENTAL INSUFFICIENCY EARLY VS LATE IUGR (>34s)

PLACENTAL DISEASE COMPENSATED HYPOXIA DECOMPENSATED HYPOXIA SERIOUS INJURYDEATH

cardiac ischemiaDiastolic failure

Systolic cardiac failure

growth

UMBILICAL A. >p95

DUCTUS VENOSUS >p95 and a-

CTG / BPP ABNORMAL

Placental injury <30%

mild hypoxiano cardiovascular adaptation

MIDDLE CEREBRAL A. <p5

CPR <p5

Centralization

Increment placental impedance

www.medicinafetalbarcelona.org/

FETAL DETERIORATION IN PLACENTAL INSUFFICIENCY EARLY VS LATE IUGR (>34s)

PLACENTAL DISEASE COMPENSATED HYPOXIA DECOMPENSATED HYPOXIA SERIOUS INJURYDEATH

growth

UMBILICAL A. >p95

CTG / BPP ABNORMAL

Placental injury <30%

mild hypoxiano cardiovascular adaptation

MIDDLE CEREBRAL A. <p5

CPR <p5

Centralization

Increment placental impedance

www.medicinafetalbarcelona.org/

FETAL DETERIORATION IN PLACENTAL INSUFFICIENCY EARLY VS LATE IUGR (>34s)

PLACENTAL DISEASE COMPENSATED HYPOXIA DECOMPENSATED HYPOXIA SERIOUS INJURYDEATH

growth

UMBILICAL A. >p95

CTG / BPP ABNORMAL

Placental injury <30%

mild hypoxiano cardiovascular adaptation

minimal tolerance to hypoxia

MIDDLE CEREBRAL A. <p5

CPR <p5

Centralization

Increment placental impedance

www.medicinafetalbarcelona.org/

FETAL DETERIORATION IN PLACENTAL INSUFFICIENCY EARLY VS LATE IUGR (>34s)

PLACENTAL DISEASE DECOMPENSATED HYPOXIA SERIOUS INJURYDEATH

growth

UMBILICAL A. >p95

CTG / BPP ABNORMAL

Placental injury <30%

mild hypoxiano cardiovascular adaptation

minimal tolerance to hypoxia

MIDDLE CEREBRAL A. <p5

CPR <p5

Centralization

Increment placental impedance

www.medicinafetalbarcelona.org/

FETAL DETERIORATION IN PLACENTAL INSUFFICIENCY EARLY VS LATE IUGR (>34s)

PLACENTAL DISEASE DECOMPENSATED HYPOXIA SERIOUS INJURYDEATH

growth

UMBILICAL A. >p95

CTG / BPP ABNORMAL

Placental injury <30%

mild hypoxiano cardiovascular adaptation

minimal tolerance to hypoxia

MIDDLE CEREBRAL A. <p5

CPR <p5

UTERINE A. >p95

Centralization

Increment placental impedance

www.medicinafetalbarcelona.org/

FETAL DETERIORATION IN PLACENTAL INSUFFICIENCY EARLY VS LATE IUGR (>34s)

PLACENTAL DISEASE DECOMPENSATED HYPOXIA SERIOUS INJURYDEATH

growth

UMBILICAL A. >p95

CTG / BPP ABNORMAL

Placental injury <30%

mild hypoxiano cardiovascular adaptation

minimal tolerance to hypoxia

MIDDLE CEREBRAL A. <p5

CPR <p5

UTERINE A. >p95

Ao ISTHMUS >p95

Centralization

Increment placental impedance

www.fetalmedicinebarcelona.org/

IUGR

SGA?

20 30 4025 35

0

3

6 %

IUGR= low CPR or high UtA or EFW<p3 or low PlGF

EARLY IUGR (1%) LATE IUGR (5-7%)

PROBLEM: MANAGEMENT PROBLEM: DIAGNOSIS

Placental disease: high (UA+, PE high) Placental disease: low (UA-, PE low)

Hypoxia ++: systemic CV adaptation Hypoxia +/-: central CV adaptation

Tolerance to hypoxia. Natural history Low tolerance: no natural history

High mortality and morbidity Low mortality but poor long outcome.

32w @diagnosis

www.medicinafetalbarcelona.org/

1. Identify small fetus

2. FGR vs. SGA

3. Early vs. Late

4. Stage-based management protocol

www.medicinafetalbarcelona.org/

IUGR = abnormal CPR or UtA or EFW<p3

Savchev 2013

www.medicinafetalbarcelona.org/

IUGR = abnormal CPR or UtA or EFW<p3

Savchev 2013

www.medicinafetalbarcelona.org/

IUGR = abnormal CPR or UtA or EFW<p3

Savchev 2013

www.medicinafetalbarcelona.org/

IUGR = abnormal CPR or UtA or EFW<p3

Savchev 2013

www.medicinafetalbarcelona.org/

IUGR = abnormal CPR or UtA or EFW<p3

Savchev 2013

Red Line EARLY IUGRRed Line LATE IUGR

www.fetalmedicinebarcelona.org/

RATIONALE FOR A STAGE-BASED APPROACH TO THE MANAGEMENT OF FGR

PLACENTAL DISEASE HYPOXIA ACIDOSIS SERIOUS INJURY DEATH

cardiac ischemiaDiastolic failure

Systolic cardiac failure

Centralization

Increment placental impedance

VIVIIIIIStage fetal deterioration

HIGHMODERATELOWRisks of prematurity

Red Line EARLY IUGRRed Line LATE IUGR

www.fetalmedicinebarcelona.org/

RATIONALE FOR A STAGE-BASED APPROACH TO THE MANAGEMENT OF FGR

PLACENTAL DISEASE HYPOXIA ACIDOSIS SERIOUS INJURY DEATH

cardiac ischemiaDiastolic failure

Systolic cardiac failure

Centralization

Increment placental impedance

cCTG: reduced STV

VIVIIIIIStage fetal deterioration

HIGHMODERATELOWRisks of prematurity

Red Line EARLY IUGRRed Line LATE IUGR

www.fetalmedicinebarcelona.org/

RATIONALE FOR A STAGE-BASED APPROACH TO THE MANAGEMENT OF FGR

PLACENTAL DISEASE HYPOXIA ACIDOSIS SERIOUS INJURY DEATH

cardiac ischemiaDiastolic failure

Systolic cardiac failure

Centralization

Increment placental impedance

cCTG: reduced STV

Diagnostic/chronic markersEarly and Late IUGR

VIVIIIIIStage fetal deterioration

HIGHMODERATELOWRisks of prematurity

Red Line EARLY IUGRRed Line LATE IUGR

www.fetalmedicinebarcelona.org/

RATIONALE FOR A STAGE-BASED APPROACH TO THE MANAGEMENT OF FGR

PLACENTAL DISEASE HYPOXIA ACIDOSIS SERIOUS INJURY DEATH

cardiac ischemiaDiastolic failure

Systolic cardiac failure

Centralization

Increment placental impedance

cCTG: reduced STV

Diagnostic/chronic markersEarly and Late IUGR

Prognostic/Acute markersEarly IUGR

VIVIIIIIStage fetal deterioration

HIGHMODERATELOWRisks of prematurity

www.medicinafetalbarcelona.org/

Protocolo CIR Primer paso: si todo N = PEG

I Doppler normal pero PFE<p3

II Aumento resistencia placentaria o redistribución inicial

III Aumento grave resistencia y/o redistribución grave

IV Alteración hemodinámica grave

V Alto riesgo de muerte

www.medicinafetalbarcelona.org/

Protocolo CIR Primer paso: si todo N = PEG

CPR<p5

Ut A >p95

MCA<p5

I Doppler normal pero PFE<p3

II Aumento resistencia placentaria o redistribución inicial

III Aumento grave resistencia y/o redistribución grave

IV Alteración hemodinámica grave

V Alto riesgo de muerte

www.medicinafetalbarcelona.org/

Protocolo CIR Primer paso: si todo N = PEG

CPR<p5

Ut A >p95

MCA<p5

I Doppler normal pero PFE<p3

II Aumento resistencia placentaria o redistribución inicial

III Aumento grave resistencia y/o redistribución grave

IV Alteración hemodinámica grave

V Alto riesgo de muerte

AEDV AoI >p95

www.medicinafetalbarcelona.org/

Protocolo CIR Primer paso: si todo N = PEG

CPR<p5

Ut A >p95

MCA<p5

REDV DV >p95 UVpuls

I Doppler normal pero PFE<p3

II Aumento resistencia placentaria o redistribución inicial

III Aumento grave resistencia y/o redistribución grave

IV Alteración hemodinámica grave

V Alto riesgo de muerte

AEDV AoI >p95

www.medicinafetalbarcelona.org/

Protocolo CIR Primer paso: si todo N = PEG

CPR<p5

Ut A >p95

MCA<p5

DV (a rev)

CGT decelerations of reduced short-term

variability

REDV DV >p95 UVpuls

I Doppler normal pero PFE<p3

II Aumento resistencia placentaria o redistribución inicial

III Aumento grave resistencia y/o redistribución grave

IV Alteración hemodinámica grave

V Alto riesgo de muerte

AEDV AoI >p95

Mort.         >90%   50%   <10%Morb.     >90%     50%

www.medicinafetalbarcelona.org/

<26w 26-28 28-32 32-34 34-37

DeliveryDV(a-­‐)

cCTG  abn.CTG  dec.

DV>p95UV  puls  REDV

(a)  AEDV(b)  AoI>95 CPR>p95

UtA>p95MCA<p5

EFW<p3

Stage V IV III II I

Mode CS CS CS  or  LI LI

IUGRManagement protocol according to severity stages

Follow-­‐up Daily 1-­‐2  d 2/w 1/w

Mort.         >90%   50%   <10%Morb.     >90%     50%

www.medicinafetalbarcelona.org/

<26w 26-28 28-32 32-34 34-37

DeliveryDV(a-­‐)

cCTG  abn.CTG  dec.

DV>p95UV  puls  REDV

(a)  AEDV(b)  AoI>95 CPR>p95

UtA>p95MCA<p5

EFW<p3

Stage V IV III II I

Mode CS CS CS  or  LI LI

IUGRManagement protocol according to severity stages

Follow-­‐up Daily 1-­‐2  d 2/w 1/w

Mort.         >90%   50%   <10%Morb.     >90%     50%

www.medicinafetalbarcelona.org/

<26w 26-28 28-32 32-34 34-37

DeliveryDV(a-­‐)

cCTG  abn.CTG  dec.

DV>p95UV  puls  REDV

(a)  AEDV(b)  AoI>95 CPR>p95

UtA>p95MCA<p5

EFW<p3

Stage V IV III II I

Mode CS CS CS  or  LI LI

IUGRManagement protocol according to severity stages

Follow-­‐up Daily 1-­‐2  d 2/w 1/w

Mort.         >90%   50%   <10%Morb.     >90%     50%

www.medicinafetalbarcelona.org/

<26w 26-28 28-32 32-34 34-37

DeliveryDV(a-­‐)

cCTG  abn.CTG  dec.

DV>p95UV  puls  REDV

(a)  AEDV(b)  AoI>95 CPR>p95

UtA>p95MCA<p5

EFW<p3

Stage V IV III II I

Mode CS CS CS  or  LI LI

IUGRManagement protocol according to severity stages

Follow-­‐up Daily 1-­‐2  d 2/w 1/w

www.medicinafetalbarcelona.org/

www.medicinafetalbarcelona.org/

The main goal in FGR is identification

www.medicinafetalbarcelona.org/

The main goal in FGR is identification

Small fetus (EFW<p10) must be divided in:

www.medicinafetalbarcelona.org/

The main goal in FGR is identification

Small fetus (EFW<p10) must be divided in: FGR (placenta, poor perinatal and long-term outcome)

www.medicinafetalbarcelona.org/

The main goal in FGR is identification

Small fetus (EFW<p10) must be divided in: FGR (placenta, poor perinatal and long-term outcome)

SGA (we don’t know, perinatal outcome N, poor long term)

www.medicinafetalbarcelona.org/

The main goal in FGR is identification

Small fetus (EFW<p10) must be divided in: FGR (placenta, poor perinatal and long-term outcome)

SGA (we don’t know, perinatal outcome N, poor long term)

Early and late-onset FGR (GA 32s) represent two distinct phenotypes of the same disease

www.medicinafetalbarcelona.org/

The main goal in FGR is identification

Small fetus (EFW<p10) must be divided in: FGR (placenta, poor perinatal and long-term outcome)

SGA (we don’t know, perinatal outcome N, poor long term)

Early and late-onset FGR (GA 32s) represent two distinct phenotypes of the same disease

Clinically, a single stage-based protocol allows optimizing decisions in all cases

www.medicinafetalbarcelona.org/

www.fetalmedicinebarcelona.org

Recommended